SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition.
Neutrophil serine proteases (NSPs), especially elastase, are major agents of lung destruction in cystic fibrosis (CF) patients. This study investigated SerpinB1, a highly efficient inhibitor of NSPs, in CF lung disease. Bronchoalveolar lavage fluid (BALF) from 31 children with CF and 24 control children was examined for amount and molecular species of SerpinB1, and its mechanism of action was studied. CF BALF had more SerpinB1 than control BALF (geometric mean 3.9 (95% CI 2.60-5.62) versus 1.37 (1.20-1.55) μg·mL⁻¹; p<0.001). BALF levels of SerpinB1 were higher for infected versus uninfected CF subjects (5.5 versus 2.7 μg·mL⁻¹; p<0.04) and substantially higher for elastase-positive versus -negative CF subjects (8.41 versus 1.89 μg·mL⁻¹; p<0.001). Most SerpinB1 in CF BALF had been cleaved. Adding recombinant SerpinB1 to CF BALF stoichiometrically inhibited endogenous elastase, indicating that the inhibitor functions in the CF microenvironment. In vitro simulations comparing SerpinB1 and α₁-antitrypsin (SerpinA1) showed that both rapidly form irreversible inhibitory covalent complexes with elastase and that these differed in survival time. The SerpinB1-elastase complex survived only briefly due to fragmentation of bound elastase, releasing cleaved SerpinB1, the molecular form in CF BALF. The findings define an innate role for SerpinB1 in CF airways.
Cooley
J
J
Immune Disease Institute, Boston, MA 02115, USA.
Sontag
M K
MK
Accurso
F J
FJ
Remold-O'Donnell
E
E
D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D003550:Cystic Fibrosis / Q000201:enzymology / Q000378:metabolism*; D006801:Humans; D019272:Leukocyte Elastase / Q000037:antagonists & inhibitors*; D015843:Serpins / Q000032:analysis / Q000378:metabolism*; D000515:alpha 1-Antitrypsin / Q000032:analysis / Q000378:metabolism
C043392:SERPINA1 protein, human; D015843:Serpins; D000515:alpha 1-Antitrypsin; C075177:SERPINB1 protein, human; D019272:Leukocyte Elastase
Am J Respir Cell Mol Biol. 1993 Oct;9(4):455-62
7691110
J Exp Med. 1989 Mar 1;169(3):833-45
2538548
J Clin Invest. 1984 Jul;74(1):236-48
6429195
Am J Respir Crit Care Med. 1995 Apr;151(4):1075-82
7697234
J Cell Biochem. 2000 Jun 12;78(4):519-32
10861849
Lung. 2003;181(2):79-88
12953146
J Biol Chem. 2001 Sep 7;276(36):33293-6
11435447
Am J Respir Cell Mol Biol. 1999 Jan;20(1):69-78
9870919
Science. 2004 Mar 5;303(5663):1532-5
15001782
J Biol Chem. 2002 Nov 1;277(44):42028-33
12189154
Am J Respir Crit Care Med. 2007 Apr 15;175(8):822-8
17234902
Eur Respir J. 1995 Jan;8(1):10-4
7744174
J Clin Invest. 1990 Jul;86(1):300-8
2164045
Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62
6035483
Thorax. 2008 Jul;63(7):621-6
18250185
Nature. 2002 Mar 21;416(6878):291-7
11907569
FEBS Lett. 1993 Jan 4;315(2):105-8
8417965
Nature. 1970 Aug 15;227(5259):680-5
5432063
Biochemistry. 2001 Dec 25;40(51):15762-70
11747453
Eur Respir J. 2008 Sep;32(3):783-95
18757703
Annu Rev Med. 1985;36:207-16
3888051
Nat Med. 2007 Dec;13(12):1423-30
18059279
J Exp Med. 2007 Aug 6;204(8):1901-9
17664292
Expert Opin Ther Targets. 2008 Feb;12(2):145-57
18208364
Thorax. 2004 Apr;59(4):318-23
15047952
Protein Expr Purif. 1998 Oct;14(1):38-44
9758749
J Biol Chem. 2006 Feb 10;281(6):3452-7
16321984
Lancet. 1991 Feb 16;337(8738):392-4
1671425
Am J Respir Cell Mol Biol. 1999 Apr;20(4):729-36
10101005
Pediatr Pulmonol. 2005 Feb;39(2):141-9
15633200
Am J Respir Crit Care Med. 1994 Jul;150(1):207-13
7912987
Chem Rev. 2002 Dec;102(12):4751-804
12475206